T1	HMM 153 212	objective response to chemotherapy using imaging modalities
T2	HMM 304 387	serum tumor markers (TMs), namely carcinoembryonic antigen, CA19-9, DUPAN-2, SPan-1
T3	HMM 455 502	Monitoring of serum TMs and computed tomography
T4	HMM 672 696	fluctuation rates of TMs
T5	HMM 872 897	time to progression (TTP)
T6	HMM 1162 1188	follows: fluctuation rates
T7	HMM 1364 1407	one-month earlier confirmation of treatment
